DLC1 induces expression of E-cadherin in prostate cancer cells through Rho pathway and suppresses invasion (Q39200334)

9 September 2017

title

DLC1 induces expression of E-cadherin in prostate cancer cells through Rho pathway and suppresses invasion (English)

1 reference

9 September 2017

1 reference

V Tripathi

1

1 reference

9 September 2017

N C Popescu

series ordinal

2

1 reference

9 September 2017

D B Zimonjic

series ordinal

3

1 reference

9 September 2017

language of work or name

English

0 references

publication date

4 February 2013

1 reference

9 September 2017

1 reference

9 September 2017

volume

33

1 reference

9 September 2017

issue

6

1 reference

9 September 2017

page(s)

724-733

1 reference

The RhoGAP protein DLC-1 functions as a metastasis suppressor in breast cancer cells

9 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.7

DLC-1: a Rho GTPase-activating protein and tumour suppressor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.7

DLC1 is a chromosome 8p tumor suppressor whose loss promotes hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.7

Ras superfamily GEFs and GAPs: validated and tractable targets for cancer therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.7

Thinking outside the box: using metastasis suppressors as molecular tools

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.7

Restoration of DLC-1 gene expression induces apoptosis and inhibits both cell growth and tumorigenicity in human hepatocellular carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.7

Adenovirus-mediated restoration of expression of the tumor suppressor gene DLC1 inhibits the proliferation and tumorigenicity of aggressive, androgen-independent human prostate cancer cell lines: prospects for gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.7

DLC-1 suppresses non-small cell lung cancer growth and invasion by RhoGAP-dependent and independent mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.7

DLC1 interaction with α-catenin stabilizes adherens junctions and enhances DLC1 antioncogenic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.7

Interaction of deleted in liver cancer 1 with tensin2 in caveolae and implications in tumor suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.7

The phosphotyrosine-independent interaction of DLC-1 and the SH2 domain of cten regulates focal adhesion localization and growth suppression activity of DLC-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.7

Oncogenic inhibition by a deleted in liver cancer gene requires cooperation between tensin binding and Rho-specific GTPase-activating protein activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.7

Full activity of the deleted in liver cancer 1 (DLC1) tumor suppressor depends on an LD-like motif that binds talin and focal adhesion kinase (FAK)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.7

21 January 2018

RHO-GTPases and cancer

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.7

Rho-family GTPases in cadherin-mediated cell-cell adhesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.7

Regulation of cell-cell junctions by the cytoskeleton.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.7

The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.7

Derailed endocytosis: an emerging feature of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.7

A causal role for E-cadherin in the transition from adenoma to carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.7

E-cadherin negatively regulates neoplastic growth in non-small cell lung cancer: role of Rho GTPases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.7

Aberrant methylation and deacetylation of deleted in liver cancer-1 gene in prostate cancer: potential clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.7

Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.7

The role of the cell-adhesion molecule E-cadherin as a tumour-suppressor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.7

p120 catenin regulates the actin cytoskeleton via Rho family GTPases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.7

E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.7

Adhesion-independent mechanism for suppression of tumor cell invasion by E-cadherin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.7

Expression of E-cadherin in prostate cancer in formalin-fixed, paraffin-embedded tissues: correlation with pathological features

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.7

Autoregulation of E-cadherin expression by cadherin-cadherin interactions: the roles of beta-catenin signaling, Slug, and MAPK

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.7

Tumor progression: Small GTPases and loss of cell-cell adhesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.7

The challenges of abundance: epithelial junctions and small GTPase signalling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.7

Rho GTPases in cell biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.7

Rho GTPases in cancer cell biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.7

Altered Rho GTPase signaling pathways in breast cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.7

RhoA mediates cyclooxygenase-2 signaling to disrupt the formation of adherens junctions and increase cell motility

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.7

Overexpression of the rhoC gene correlates with progression of ductal adenocarcinoma of the pancreas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.7

Genomic analysis of metastasis reveals an essential role for RhoC

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.7

Characterization of the roles of RHOC and RHOA GTPases in invasion, motility, and matrix adhesion in inflammatory and aggressive breast cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.7

Rho GTPases in PC-3 prostate cancer cell morphology, invasion and tumor cell diapedesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.7

ROCK and Dia have opposing effects on adherens junctions downstream of Rho

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.7

Deleted in liver cancer 1 (DLC1) negatively regulates Rho/ROCK/MLC pathway in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.7

In vitro and in vivo assays to analyze the contribution of Rho kinase in angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.7

The Rho/ROCK pathway for lysophosphatidic acid-induced proteolytic enzyme expression and ovarian cancer cell invasion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.7

Loss of E-cadherin promotes ovarian cancer metastasis via alpha 5-integrin, which is a therapeutic target

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.7

Luteolin inhibits invasion of prostate cancer PC3 cells through E-cadherin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.7

Reversion of the malignant phenotype of human breast cells in three-dimensional culture and in vivo by integrin blocking antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.7

Peroxisome proliferator-activated receptor gamma regulates E-cadherin expression and inhibits growth and invasion of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.7

DLC1: a significant GAP in the cancer genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.7

Sequential down-regulation of E-cadherin with squamous cell carcinoma progression: loss of E-cadherin via a prostaglandin E2-EP2 dependent posttranslational mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.7

Role of DLC1 tumor suppressor gene and MYC oncogene in pathogenesis of human hepatocellular carcinoma: potential prospects for combined targeted therapeutics (review)

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.7

31 March 2020

Identifiers

DOI

10.1038/ONC.2013.7

1 reference

9 September 2017

1 reference